Old Web
English
Sign In
Acemap
>
authorDetail
>
Chad E. Glasser
Chad E. Glasser
University of Kentucky
Phases of clinical research
Physical therapy
Increase muscle mass
Medicine
in patient
3
Papers
116
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results of the Dose-Escalation Portion of a Phase 2 Study of ACE-083, a Local Muscle Therapeutic, in Patients with Charcot-Marie-Tooth (CMT) Disease (S58.006)
2019
Neurology
Florian P. Thomas
Michael E. Shy
David N. Herrmann
Jeffrey M. Statland
David Walk
Colin Quinn
Nicholas E. Johnson
S Subramony
Chafic Karam
Tahseen Mozaffar
Chad E. Glasser
Barry Miller
Ashley Leneus
Robert K. Zeldin
Kenneth M. Attie
Show All
Source
Cite
Save
Citations (0)
Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001)
2018
Neurology
Jeffrey M. Statland
Anthony A. Amato
Elena Bravver
Craig Campbell
Lauren Elman
Nicholas E. Johnson
Nanette C. Joyce
Chafic Karam
John T. Kissel
Lawrence Korngut
Erin K. O'Ferrall
Georgios Manousakis
Alan Pestronk
Perry B. Shieh
Rabi Tawil
Ashley Leneus
Barry Miller
Matthew L. Sherman
Chad E. Glasser
Kenneth M. Attie
Show All
Source
Cite
Save
Citations (0)
Tissue expression patterns identify mouse cilia genes.
2008
Physiological Genomics
Timothy S. McClintock
Chad E. Glasser
Soma C. Bose
Daniel A. Bergman
Show All
Source
Cite
Save
Citations (116)
1